THYROCARE TECHNOLOGIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 644.1 INR | -0.11% |
|
+1.57% | +0.09% |
Presentation Operator MessageOperator (Operator)Ladies and gentlemen, good day, and welcome to...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Thyrocare Technologies Limited is an India-based healthcare services provider in diagnostic area. The Company has diagnostic chains that conduct a range of medical diagnostic tests and profiles of tests that is focused on early detection and management of health disorders and diseases. The Company's segments include Diagnostic Testing Services, Imaging Services and Others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services includes diagnostic and imaging services, selling of radio-pharmaceutical, selling of consumables for reporting. The Others segment include the sale of testing equipment and consumables, and selling of glucometer and glucostrips under the brand, Sugarscan. The Company has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, a medical cyclotron facility and PET-CT facilities across India.
Calendar
2024-07-30
- Q1 2025 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
644.8
INR
Average target price
740
INR
Spread / Average Target
+14.76%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.09% | 409M | |
| -18.64% | 8.32B | |
| +70.43% | 4.38B | |
| +11.92% | 2.9B | |
| -2.45% | 2.65B | |
| -15.14% | 1.75B | |
| -58.41% | 1.66B | |
| -16.63% | 1.49B | |
| +24.33% | 1.28B | |
| -50.73% | 999M |
- Stock Market
- Equities
- THYROCARE Stock
- News Thyrocare Technologies Limited
- Transcript : Thyrocare Technologies Limited, Q2 2024 Earnings Call, Oct 31, 2023
